1
|
Biglin ER, Aitkenhead AH, Price GJ, Chadwick AL, Santina E, Williams KJ, Kirkby KJ. A preclinical radiotherapy dosimetry audit using a realistic 3D printed murine phantom. Sci Rep 2022; 12:6826. [PMID: 35474242 PMCID: PMC9042835 DOI: 10.1038/s41598-022-10895-5] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/13/2021] [Accepted: 04/05/2022] [Indexed: 11/08/2022] Open
Abstract
Preclinical radiation research lacks standardized dosimetry procedures that provide traceability to a primary standard. Consequently, ensuring accuracy and reproducibility between studies is challenging. Using 3D printed murine phantoms we undertook a dosimetry audit of Xstrahl Small Animal Radiation Research Platforms (SARRPs) installed at 7 UK centres. The geometrically realistic phantom accommodated alanine pellets and Gafchromic EBT3 film for simultaneous measurement of the dose delivered and the dose distribution within a 2D plane, respectively. Two irradiation scenarios were developed: (1) a 10 × 10 mm2 static field targeting the pelvis, and (2) a 5 × 5 mm2 90° arc targeting the brain. For static fields, the absolute difference between the planned dose and alanine measurement across all centres was 4.1 ± 4.3% (mean ± standard deviation), with an overall range of - 2.3 to 10.5%. For arc fields, the difference was - 1.2% ± 6.1%, with a range of - 13.1 to 7.7%. EBT3 dose measurements were greater than alanine by 2.0 ± 2.5% and 3.5 ± 6.0% (mean ± standard deviation) for the static and arc fields, respectively. 2D dose distributions showed discrepancies to the planned dose at the field edges. The audit demonstrates that further work on preclinical radiotherapy quality assurance processes is merited.
Collapse
Affiliation(s)
- Emma R Biglin
- Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, 3rd floor Proton Beam Therapy Centre, Oak Road, Manchester, M20 4BX, UK.
| | - Adam H Aitkenhead
- Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, 3rd floor Proton Beam Therapy Centre, Oak Road, Manchester, M20 4BX, UK
- Christie Medical Physics and Engineering, The Christie NHS Foundation Trust, Manchester, UK
| | - Gareth J Price
- Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, 3rd floor Proton Beam Therapy Centre, Oak Road, Manchester, M20 4BX, UK
- The Christie NHS Foundation Trust, Manchester, UK
| | - Amy L Chadwick
- Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, 3rd floor Proton Beam Therapy Centre, Oak Road, Manchester, M20 4BX, UK
- The Christie NHS Foundation Trust, Manchester, UK
| | - Elham Santina
- Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, 3rd floor Proton Beam Therapy Centre, Oak Road, Manchester, M20 4BX, UK
- The Christie NHS Foundation Trust, Manchester, UK
| | - Kaye J Williams
- Division of Pharmacy and Optometry, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK
| | - Karen J Kirkby
- Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, 3rd floor Proton Beam Therapy Centre, Oak Road, Manchester, M20 4BX, UK
- The Christie NHS Foundation Trust, Manchester, UK
| |
Collapse
|
2
|
McCarthy D, Kenny P. Extended detail contrasts for TO.10 use on flat panel detector fluoroscopy systems. Br J Radiol 2021; 94:20201422. [PMID: 33956486 DOI: 10.1259/bjr.20201422] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022] Open
Abstract
OBJECTIVES Leeds Test Object Ten (TO.10) is routinely used to subjectively estimate Threshold Contrast Detail Detectability (TCDD) as a measure of image quality in fluoroscopy. However, manufacturer guidance provides calibrated contrasts for only limited peak voltage and copper filtration thickness combinations. Prescribed testing conditions are often difficult to attain as modern flat panel fluoroscopic systems independently determine voltage and copper filtration thickness settings. This work aims to extend the range of TO.10 contrasts available for routine testing at peak voltage and copper thickness settings likely to be encountered. METHODS Two methods are described for generalising the calculation of target contrasts: a three-dimensional interpolation/extrapolation model in MATLAB®, and a multivariate log-polynomial function. Both methods utilise the available calibrated contrasts to estimate contrasts at voltage and copper thickness combinations routinely encountered. RESULTS Results are presented as Threshold Detection Index [Formula: see text] curves fit by a second-order polynomial of log [Formula: see text] to log [Formula: see text] . Results are found to be more accurate at unprescribed conditions while also reproducible for relatively consistent input air kerma rate (IAKR) expected from automatic dose rate controls (ADRC). CONCLUSIONS The calculation of TO.10 contrasts at non-standard conditions aids in the determination of an absolute estimate of image quality in fluoroscopy with greater accuracy, reproducibility and efficiency. ADVANCES IN KNOWLEDGE TO.10 detail contrasts for TCDD testing of fluoroscopy units have been significantly extended beyond those previously available. The described methods will aid the clinical physicist in absolute assessments of fluoroscopic image quality and facilitate inter system comparisons.
Collapse
Affiliation(s)
- Dean McCarthy
- Mater Misericordiae University Hospital, Dublin, Ireland
| | - Patrick Kenny
- Mater Misericordiae University Hospital, Dublin, Ireland
| |
Collapse
|